E. Mamizhev, V. Osetnik, I. B. Dzalilov, B. Aslanov, A. Artemyeva, A. Nosov, S. Gadaev
{"title":"睾丸和睾丸旁组织的鳞状细胞癌","authors":"E. Mamizhev, V. Osetnik, I. B. Dzalilov, B. Aslanov, A. Artemyeva, A. Nosov, S. Gadaev","doi":"10.17650/1726-9776-2019-15-4-108-112","DOIUrl":null,"url":null,"abstract":"Testicular tumors occur in 1–1.5 % of cases in the structure of the general oncological morbidity among men and constitute 5 % among tumors of the urogenital tract. In Western Europe, 3–6 new cases are recorded a year per 100 thousand male population. Nevertheless, in relation to young men, this particular type of neoplasm is not only the most common oncological pathology (up to 60 % of all neoplasms), but also the main cause of cancer mortality. Risk factors for developing ovarian cancer include a family history, previous development of a tumor in the contralateral testicle, and components of testicular dysgenesis syndrome (cryptorchidism, hypospadias, spermatogenesis disorders leading to infertility). Tumors of paratesticular tissues are much less common and most of them are benign. Squamous cell carcinoma rarely develops as a primary tumor of the testis and / or paratesticular tissue, isolated cases have been described in the English literature. Secondary damage to the scrotum organs is more frequent, but such situations are usually found in patients of an older age group. This article presents the clinical case and the final results of treatment of a patient with squamous cell carcinoma of paratesticular tissue.","PeriodicalId":42924,"journal":{"name":"Onkourologiya","volume":"1 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2020-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Squamous cell carcinoma of the testis and paratesticular tissue\",\"authors\":\"E. Mamizhev, V. Osetnik, I. B. Dzalilov, B. Aslanov, A. Artemyeva, A. Nosov, S. Gadaev\",\"doi\":\"10.17650/1726-9776-2019-15-4-108-112\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Testicular tumors occur in 1–1.5 % of cases in the structure of the general oncological morbidity among men and constitute 5 % among tumors of the urogenital tract. In Western Europe, 3–6 new cases are recorded a year per 100 thousand male population. Nevertheless, in relation to young men, this particular type of neoplasm is not only the most common oncological pathology (up to 60 % of all neoplasms), but also the main cause of cancer mortality. Risk factors for developing ovarian cancer include a family history, previous development of a tumor in the contralateral testicle, and components of testicular dysgenesis syndrome (cryptorchidism, hypospadias, spermatogenesis disorders leading to infertility). Tumors of paratesticular tissues are much less common and most of them are benign. Squamous cell carcinoma rarely develops as a primary tumor of the testis and / or paratesticular tissue, isolated cases have been described in the English literature. Secondary damage to the scrotum organs is more frequent, but such situations are usually found in patients of an older age group. This article presents the clinical case and the final results of treatment of a patient with squamous cell carcinoma of paratesticular tissue.\",\"PeriodicalId\":42924,\"journal\":{\"name\":\"Onkourologiya\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2020-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Onkourologiya\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/1726-9776-2019-15-4-108-112\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Onkourologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/1726-9776-2019-15-4-108-112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Squamous cell carcinoma of the testis and paratesticular tissue
Testicular tumors occur in 1–1.5 % of cases in the structure of the general oncological morbidity among men and constitute 5 % among tumors of the urogenital tract. In Western Europe, 3–6 new cases are recorded a year per 100 thousand male population. Nevertheless, in relation to young men, this particular type of neoplasm is not only the most common oncological pathology (up to 60 % of all neoplasms), but also the main cause of cancer mortality. Risk factors for developing ovarian cancer include a family history, previous development of a tumor in the contralateral testicle, and components of testicular dysgenesis syndrome (cryptorchidism, hypospadias, spermatogenesis disorders leading to infertility). Tumors of paratesticular tissues are much less common and most of them are benign. Squamous cell carcinoma rarely develops as a primary tumor of the testis and / or paratesticular tissue, isolated cases have been described in the English literature. Secondary damage to the scrotum organs is more frequent, but such situations are usually found in patients of an older age group. This article presents the clinical case and the final results of treatment of a patient with squamous cell carcinoma of paratesticular tissue.
期刊介绍:
The main objective of the journal "Cancer urology" is publishing up-to-date information about scientific clinical researches, diagnostics, treatment of oncologic urological diseases. The aim of the edition is to inform the experts on oncologic urology about achievements in this area, to build understanding of the necessary integrated interdisciplinary approach in therapy, alongside with urologists, combining efforts of doctors of various specialties (cardiologists, pediatricians, chemotherapeutists et al.), to contribute to raising the effectiveness of oncologic patients’ treatment.